Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Bispectral Index Values by Estimated Effect-site Concentration of Propofol and Remifentanil Displayed on the Target-centered Infusion Pump

NCT01604226 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01604226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01604226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Bispectral Index Values by Estimated Effect-site Concentration of Propofol and Remifentanil Displayed on the Target-centered Infusion Pump
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2012
Completion date
December 31, 2014
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bispectral index monitoring, general anesthesia, total intravenous anesthesia